Rapid, Point-of-Care Extraction of Human Immunodeficiency Virus Type 1 Proviral DNA from Whole Blood for Detection by Real-Time PCR

Por Jangam, Sujit R., Yamada, Douglas H., McFall, Sally M., Kelso, David M.
Publicado em 2009

Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection

Por Wilson, Elizabeth B., Yamada, Douglas H., Elsaesser, Heidi, Herskovitz, Jonathan, Deng, Jane, Cheng, Genhong, Aronow, Bruce J., Karp, Christopher L., Brooks, David G.
Publicado em 2013

Suppression of Fcγ-Receptor-Mediated Antibody Effector Function during Persistent Viral Infection

Por Yamada, Douglas H., Elsaesser, Heidi, Lux, Anja, Timmerman, John M., Morrison, Sherie L., de la Torre, Juan Carlos, Nimmerjahn, Falk, Brooks, David G.
Publicado no Immunity (2015)

Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection

Por Osokine, Ivan, Snell, Laura M., Cunningham, Cameron R., Yamada, Douglas H., Wilson, Elizabeth B., Elsaesser, Heidi J., de la Torre, Juan Carlos, Brooks, David
Publicado em 2014

Limiting cholesterol biosynthetic flux spontaneously engages type I IFN signaling

Por York, Autumn G., Williams, Kevin J., Argus, Joseph P., Zhou, Quan D., Brar, Gurpreet, Vergnes, Laurent, Gray, Elizabeth E., Zhen, Anjie, Wu, Nicholas C., Yamada, Douglas H., Cunningham, Cameron R., Tarling, Elizabeth J., Wilks, Moses Q., Casero, David, Gray, David H., Yu, Amy K., Wang, Eric S., Brooks, David G., Sun, Ren, Kitchen, Scott G., Wu, Ting-Ting, Reue, Karen, Stetson, Daniel B., Bensinger, Steven J.
Publicado no Cell (2015)